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The pathogenesis of degenerative disc disease is a complex and multifactorial process
in which genetics, mechanical trauma, altered loading and nutrition present significant
etiological factors. Infection of the intervertebral disc with the anaerobic bacterium
Propionibacterium acnes is now also emerging as a potentially new etiological factor. This
human commensal bacterium is well known for its long association with the inflammatory
skin condition acne vulgaris. A key component of inflammatory responses to P. acnes
in acne appears to be interleukin (IL)-1β. Similarly, in degenerative disc disease (DDD)
there is compelling evidence for the fundamental roles of IL-1β in its pathology. We
therefore propose that P. acnes involvement in DDD is biologically very plausible, and that
IL-1β is the key inflammatory mechanism driving the host response to P. acnes infection.
Since there is a solid theoretical basis for this phenomenon, we further propose that the
relationship between P. acnes infection and DDD is causal.
Keywords: Propionibacterium acnes, interleukin-1 beta, nerve growth factor (NGF), degenerative disc disease,
acne vulgaris
THE CLINICAL PROBLEM AND EPIDEMIOLOGICAL EVIDENCE
OF PROPIONIBACTERIUM ACNES IN DEGENERATIVE DISC
DISEASE
Chronic low back pain (CLBP) is the leading cause of disability/worker’s compensation claims,
second leading cause for patient-doctor visits, the thirdmost common cause of surgical procedures,
and the fifth-ranking cause of admission to hospital (Hart et al., 1995). Although many conditions
lead to CLBP, degenerative disc disease (DDD) is among the most common diagnoses. Because
correlations among clinical symptoms, radiological signs of disc degeneration, and treatment
outcomes are not satisfactory, the selection of treatment options is difficult and the options
employed often yield less than satisfactory results. Clearly, a more detailed understanding of the
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causes and development of DDD is needed so patients can be
stratified for tailored or personalized treatments where possible.
The identification of Propionibacterium acnes biofilms in
intervertebral disc tissue obtained from patients who have
undergone microdiscectomy, combined with previous studies
demonstrating the success of antibiotic treatment for patients
with CLBP (Albert et al., 2013), has led to the suggestion that
P. acnes infection of the intervertebral disc may be another
important causative factor for the development of DDD. The
mechanisms by which P. acnes infection may lead to DDD have,
however, yet to be elucidated. Here, we propose a model of
P. acnes pathogenicity in DDD in which patients may benefit
from biomarker-directed anti-inflammatory interventions, such
as already available biologic drugs or small molecule inhibitors
that could be re-purposed for amore precision-based approach to
treatment, in combination with antibiotic or other antimicrobial
treatments.
The seminal, potentially paradigm-shifting study that first
provided evidence to link P. acnes infection of the degenerated
disc to CLBP was published by Stirling et al. (2001). Since then,
the role of this bacterium in CLBP has received considerable
attention, as well as controversy, due to the possibility of novel
treatment options for this debilitating condition (Birkenmaier,
2013). Subsequent independent research into this exciting area
has been collectively examined in two independentmeta-analyses
published in 2015. These studies reported that the pooled
prevalence of bacterial infection was 34% (Urquhart et al., 2015)
or 36.2% (Ganko et al., 2015), and confirmed P. acnes as the
major bacterial species present in retrieved disc samples. Very
recently, P. acnes was further identified as the only significant
bacterial organism present in degenerated disc tissue obtained
from 32% of 368 patients undergoing microdiscectomy (Capoor
et al., 2017). Importantly, this study also provided the first
microscopic evidence of P. acnes biofilm within degenerated
disc tissue as shown in Figures 1, 2 (Capoor et al., 2017).
The presence of biofilm, which is consistent with colonization/
infection rather than perioperative contamination, which is a key
concern when dealing with an organism which also forms part of
the endogenous microbiota, provided compelling evidence that
at least some of the culture-positive degenerated disc tissue had
truly become infected with P. acnes (Capoor et al., 2017). Both
rabbit and rat models have also shown that P. acnes infection of
disc tissue can induce disc degeneration, inflammatory response
in the endplate region andMC1-like changes in the adjacent bone
marrow (Dudli et al., 2016; Shan et al., 2017).
A KEY ROLE FOR IL-1β IN P. ACNES
DRIVEN ACNE VULGARIS
The involvement of P. acnes in acne was first suggested as early
as 1896 when Unna isolated the bacterium from an acne lesion
(Unna, 1895). Even since then, the exact role the organism plays
in the initiation and progression of this chronic inflammatory
skin condition remains unclear, especially as some inflamed
lesions show no evidence of viable bacterial colonization and
no correlation exists between bacterial counts and severity of
inflammation (Shaheen and Gonzalez, 2011). Acne samples do,
however, demonstrate a higher prevalence of follicular P. acnes
colonization, both in terms of follicles containing P. acnes and
the greater numbers of bacteria in macrocolonies/biofilms than
in control samples (Jahns et al., 2012). The strong inflammatory
potential of P. acnes is well known, and the bacterium can
upregulate a wide range of inflammatory cytokines (e.g., TNFα,
IL-6, IL-8, IL-1 family) and activate keratinocytes and sebocytes
via CD1, CD14, and Toll-like receptors (TLRs) (Moradi Tuchayi
et al., 2015). The bacterium can also induce the expression of IL-
17 from peripheral blood mononuclear cells and promote Th17
and Th1 response pathways (Agak et al., 2014); activation of the
Th17 axis and Th17 cytokines (IL-17, IL-1β, IL-6, and TGF-β)
appears to play a pivotal role in acne (Sardana and Verma, 2017).
Furthermore, the organism produces lipases which facilitate
breakdown of the sebum (carbon source) into free short chain
fatty acids which are pro-inflammatory (Sanford et al., 2016). The
critical role of the IL-1 family of cytokines in the pathogenesis
of acne vulgaris, especially IL-1β which is abundant in acneic
lesions, has now been well described (Kistowska et al., 2014). This
strongly pro-inflammatory cytokine has been associated with IL-
17 production highlighting the strong link between IL-1β and
IL-17 immunity (Lasigliè et al., 2011).
The induction of IL-1β is believed to be a key driver
of inflammatory responses in acne and is mediated via
inflammasome activation (Kistowska et al., 2014). We can easily
envisage, therefore, how P. acnes pathogen-associated molecular
patterns (PAMPs) will bind to TLR2 on sebocytes (Li et al.,
2014) and myeloid cells (Kistowska et al., 2014), activating
NF-κB signaling and consequently transcription of the IL-1β
gene, thus leading to the production of pro-IL-1β within the
pilosebaceous unit. This initial interaction between P. acnes
and myeloid cells can occur either by migration of the latter
into the follicular space or by leakage of P. acnes into the
peri-follicular space. Myeloid cells and sebocytes constitutively
express inflammasome proteins. P. acnes PAMPs trigger NLRP3
inflammasome activation, resulting in increased caspase 1
activity, facilitated cleavage of pro-IL-1β, and excessive release
of mature IL-1β. Furthermore, IL-1β promotes dermal matrix
destruction by inducing proteolytic matrix metalloproteases
(MMPs). Progression of the inflammation results in P. acnes
overgrowth and follicular obstruction, which provokes follicular
rupture. P. acnes can then leak out of the pilosebaceous unit
and get into close contact with the peri-follicular myeloid cells,
finally leading to excessive release of IL-1β and neutrophil-rich
peri-follicular inflammation.
A KEY ROLE FOR IL-1β IN DEGENERATIVE
DISC DISEASE
Disc degeneration is also known to be mediated by the abnormal
secretion of pro-inflammatory cytokines by the inner nucleus
pulposus (NP) and outer annulus fibrosus (AF) cells of the
intervertebral disc, as well as by immune cells attracted to the
site of disc degeneration. These cytokines, including IL-1α, IL-
1β, IL-6, IL-8, IL-17, TNF-α and IFN-γ, serve to promote a
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FIGURE 1 | Visualization of bacterial biofilm in the disc tissue by confocal laser scanning microscopy (CSLM) and confirmation of P. acnes by fluorescence in-situ
hybridization (FISH) (reprinted from Capoor et al., 2017). (A) Three dimensional reconstructed CSLM image of biofilm bacteria stained with a DNA stain (SYTO9, green)
in a disc tissue sample. (B,C) The presence of P. acnes biofilms in this sample verified using FISH. Epifluorescence micrographs of a biofilm cluster showing red
fluorescence from the CY5-labeled EUB338 general eubacterial probe (B) and green fluorescence from the CY3-labled P. acnes-specific probe (C) Co-localization of
the red and green fluorescence indicates that all of the bacteria in this biofilm were P. acnes.
range of pathogenic responses by disc cells including matrix
breakdown and immune cell recruitment (Risbud and Shapiro,
2014). As with acne vulgaris, IL-1β appears to play a key role
in disc degeneration, including matrix destruction, angiogenesis
and cellular apoptosis and senescence (Yang et al., 2015). Levels
of the cytokine in degenerated discs also appear to correlate
with the degree of degeneration (Le Maitre et al., 2005). Also,
IL-17 expression is increased in degenerated discs as well as
intervertebral disc cells exposed to IL-1β (Le Maitre et al.,
2005; Yang et al., 2015). As in acne, we see an infiltration of
CD68+macrophages, neutrophils and T cells (CD4+; CD8+) in
herniated discs (Risbud and Shapiro, 2014).
Irrespective of the initiating factor in DDD, it is thought
to trigger NF-κB signaling through TLRs, which stimulates the
production of pro-IL-1β (Risbud and Shapiro, 2014). Increased
levels of NLRP3 and caspase-1 have also been described in
degenerated disc tissue, indicating inflammasome activation
and facilitated maturation of pro-IL-1β (Chen et al., 2015).
Inflammatory actions are further amplified because IL-1β is
not only an NF-κB target gene, but also an NF-κB activator,
forming a positive feedback loop (Chen et al., 2015). This IL-
1β/IL-1 receptor (IL-1R) signaling promotes extracellular matrix
degradation through the induction of proteolytic enzymes,
including MMPs 1, 2, 3, 9, and 13 and aggrecanases of “a
disintegrin and metalloproteinase with thrombospondin motifs’
(ADAMTS) families 4/5 (Le Maitre et al., 2007). Specific
damage-associated molecular patterns (DAMPs), which include
fragmented collagen, aggrecan, or hyaluronic acid, bind to TLRs
on NP and AF cells and activate NF-κB, forming another positive
feedback loop (Quero et al., 2013). IL-1β also promotes the
production of chemotactic CC-chemokines, mainly CCL3 and
CCL4, leading to the recruitment and activation of infiltrating
immune cells that further amplify the inflammatory cascade
(Wang et al., 2013). These pathways form the core of a model
in which P. acnes infection causes IL-1β release by NP, AF and
immune cells, which leads to extracellular matrix degradation
within the intervertebral disc (Nazipi et al., 2017).
The ingrowth of nociceptive nerve fibers into the degenerated
disc, usually accompanied by the presence of annular fissures,
is considered a main source of nociception related to CLBP
(Freemont et al., 1997). IL-1β has been shown to induce the
expression of neurotrophin-like nerve growth factor (NGF) and
brain-derived neurotrophic factor (BDNF) in both disc and
immune cells, supporting nerve ingrowth into the degenerated
disc (Gruber et al., 2012). IL-1β-stimulated NGF and BDNF
production further induces expression of pain-associated cation
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FIGURE 2 | Visualization of P. acnes biofilm in the disc tissue by use of FISH (reprinted from Capoor et al., 2017). (A) This color-combined image shows the “pocket”
of green fluorescent P. acnes cells (biofilm) near the center right of the image. The presence of P. acnes biofilms in this sample was verified using FISH. (B,C) Red
fluorescence is the general eubacterial probe (B) and green is the P. acnes probe (C). The (B,C) image is a zoom of (A) showing fluorescence from the red and green
channels separately. Almost all of the cells in (A) are emitting both red and green fluorescence, indicating that they are P. acnes.
channels in the dorsal root ganglion (Risbud and Shapiro, 2014),
the depolarization of which is likely to promote low back and
radicular pain. Finally, NGF has a direct activating or sensitizing
effect on nociceptors, and its upregulation in CLBP has been
demonstrated (Denk et al., 2017).
HYPOTHESIS: THE CENTRAL ROLE OF
IL-1β IN DDD IS EVIDENCE OF A
P. ACNES-DRIVEN ETIOLOGY
Based on the (i) compelling epidemiological evidence (Stirling
et al., 2001; Urquhart et al., 2015; Capoor et al., 2016, 2017; Coscia
et al., 2016), (ii) the uniqueness of P. acnes in the degenerated disc
tissue (Capoor et al., 2017), (iii) direct microscopic evidence of
P. acnes biofilm in degenerated disc tissue, as shown in Figures 1,
2 (Capoor et al., 2017), (iv) experimental data showing P. acnes
induces disc degeneration in animal models (Dudli et al., 2016;
Shan et al., 2017), and (v) the shared central role of IL-1β within
acne vulgaris and DDD (Le Maitre et al., 2005; Wuertz and
Haglund, 2013), we hypothesize, that a role for P. acnes in the
etiology of DDD is biologically plausible, with IL-1β expression
representing the driving mechanism behind its pathogenesis.
As shown in Figure 3, P. acnes can affect the initiation and/or
progression of DDD by stimulating IL-1β synthesis through
several potential routes: (i) P. acnes infection can promote IL-
1β production by AF and NP cells through a direct interaction
between P. acnes-specific PAMPs and TLR2 on the surfaces of
NP and AF cells, which activates NF-κB signaling and leads
to the production of pro-IL-1β; (ii) hyaluronidase released by
P. acnes cleaves hyaluronic acid within the disc matrix to form
short fragments with ability to activate NF-κB signaling leading
to production of pro-IL-1β; (iii) P. acnes-specific PAMPs can
also activate NLRP3-inflammasome and caspase-1, which can
convert pro-IL-1β to mature IL-1β; (iv) the IL-1β produced
through the action of P. acnes can amplify inflammatory signaling
through interaction with IL-1R, which creates a positive feedback
loop; and (v) the IL-1β produced can further unleash signaling
pathways that lead to the production of MMPs and ADAMTS,
which degrade the extracellular matrix, producing P. acnes-
related DAMPs that can interact with AF, NP, and myeloid cells
to further activate NF-κB signaling and produce a second positive
feedback loop.
Since there are several independent routes by which P. acnes
can promote the synthesis of IL-1β, and there is a positive
feedback loop in the regulation of IL-1β levels, we propose that
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FIGURE 3 | IL-1β driven degenerative state in acne vulgaris and degenerative disc disease. Following the initiating event, sebocytes and NP and AF cells promote
production of IL-1β. IL-1β signaling facilitates extracellular matrix degradation through induction of proteolytic enzymes, including MMPs and ADAMTS4/5. P. acnes
PAMPs and extracellular matrix degradation products DAMPs (e.g., fragmented collagen, aggrecan, and hyaluronic acid) bind to TLRs, which activate NF-κB, leading
to the synthesis of pro-IL-1β; P. acnes PAMPs also activate inflammasomes (NLRP3) and caspase-1, which convert pro-IL-1β to IL-1β. IL-1β stimulates production of
CC-chemokines that recruit myeloid cells and proteolytic matrix metalloproteases (MMPs) that degrade the ECM. Positive feedback loops arise when IL-1β binds to
IL-1R and when extracellular matrix degradation products (DAMPs, e.g., fragmented collagen) activate TLRs. Both binding events stimulate IL-1β production.
Inflammatory signaling is amplified since IL-1β is not only NF-κB target gene, but also its activator through binding to IL-R1. The nerve ingrowth into the degenerated
disc, usually accompanied by presence of the annular fissures eventually herniation, is considered a main source of nociception and thus low back and/or radicular
pain. IL-1β induces the expression of neurotrophins like NGF and BDNF supporting the nerve. ADAMTS-4/5, a disintegrin and metalloproteinase with thrombospondin
motifs 4/5; AF, annulus fibrosus; BDNF, brain-derived neurotrophic factor; DAMPs, damage-associated molecular patterns; PAMPs, pathogen-associated molecular
patterns; DDD, degenerative disc disease; ECM, extracellular matrix; IL-1R, interleukin-1 receptor; MMPs, matrix metalloproteinases; NF-κB, nuclear factor κB; NGF,
nerve growth factor; NP, nucleus pulposus; TLRs, Toll-like receptors.
P. acnes is a strong contributor to IL-1β-based pathogenetic
mechanisms that lead to DDD. We further hypothesize that if
there are other etiological factors contributing to DDD through
the promotion of IL-1β, P. acnes significantly amplifies the
significance of this pre-existing IL-1β action and facilitates the
pathogenesis in synergy with other etiological factors of DDD.
Furthermore, we propose that in some patients where no
P. acnes is detected directly by culture- or non-culture methods
within disc material, the central role of IL-1β may still be a
“smoking gun” for an infection that may no longer be present but
has created a state of chronic inflammation and bone destruction
that still persists in some form.
Finally, complex inherited alterations in the inflammasome/
IL-1β system may fine-tune its functional capacity and cause
an imbalance of pro- and anti-inflammatory responses that
determine the individual risk, time of onset, and severity of
P. acnes-associated DDD.
TESTING THE HYPOTHESIS AND
IMPLICATIONS FOR HEALTH CARE
PROVISION
Since there is strong experimental evidence of IL-1β involvement
in the pathogenesis of DDD (Wuertz and Haglund, 2013; Risbud
and Shapiro, 2014), our aim here is to propose experimental
approaches to assess the ability and mechanism by which P. acnes
promotes IL-1β synthesis and function, and not to prove its
effects on DDD pathogenesis per se. NP and AF cells have been
shown to express TLR2 (Le Maitre et al., 2005), and there is
evidence of P. acnes interactionwith TLR2 (Kistowska et al., 2014;
Li et al., 2014). Therefore, the ability of P. acnes to induce IL-
1β should be demonstrated by monitoring IL-1β levels in NP
and AF cell cultures and in vivo models of DDD that have been
infected with P. acnes strains isolated from degenerated human
discs, and covering different phylogenetic groups that are known
to vary in their inflammatory nature as well as other pathogenic
characteristics (McDowell et al., 2013). Since P. acnes has been
shown to form biofilm in DDD, its ability to promote IL-1β
production should be compared with heavy biofilm formers and
isolates that fail to actively form biofilms (Holmberg et al., 2009).
Finally, clinical samples of degenerated disc tissue shown to be
infected with P. acnes should be associated with IL-1β levels
higher than those seen with non-infected degenerated discs.
The ability of P. acnes to activate TLR2 signaling in myeloid
cells, especially macrophages, has been already demonstrated in
acne vulgaris confirming another route of P. acnes-associated IL-
1β production. Finally, short fragments of hyaluronic acid have
been shown to interact with TLR2 present on NP cells (Quero
et al., 2013), providing evidence for the P. acnes-associated IL-
1β production, through hyaluronidase secretion. To provide
a definitive test of the hypothesis that P. acnes is a strong
contributor to IL-1β-based DDD pathogenesis, in vitro and in
vivo experiments will be performed to quantitatively compare
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 5 August 2018 | Volume 8 | Article 272
Slaby et al. IL-1β, P. acnes and Disc Degeneration
the ability of P. acnes to induce IL-1β with that of other known
activators of IL-1β commonly used in DDD.
To identify the concrete mechanisms affecting the propensity
of P. acnes to activate the various routes of IL-1β induction,
the following experimental approaches could be used in vitro
and in animal models: (i) a series of knock-in and knock-
down experiments of the critically important genes linked to
various mechanisms of IL-1β induction and functioning (e.g.,
TLR2, NLR3, MyD88 or caspase-1), (ii) experiments with a panel
of inhibitors specifically affecting signaling pathways associated
with the complex cascade of IL-1β processing and function, and
finally (iii) experiments with models for which the signaling
ligands are naturally or experimentally altered.
Evidence that P. acnes infection may incite a chronic
inflammatory response that persists after the organism is no
longer present could be investigated via serological studies
and analysis of samples for bacterial products and signature
metabolites that could still be perpetuating inflammation
(Magnitsky et al., 2017), or via a series of model infections in
which animals will be treated for P. acnes with antibiotics over
a wide range of time-points post-infection and the grade of disc
degeneration compared between the groups. A prior history of
moderate-to-severe acne vulgaris may also be important in this
context as has been shown in relation to the potential role of
P. acnes in prostate cancer (Ugge et al., 2018).
Even if the hypothesis put forward here turns out to be
incorrect or only partially correct, it will at least have served to
stimulate more research on the potential role of P. acnes in DDD,
which is vitally important because of the potential benefits for
patients and wider society.
The main clinical presentation of DDD is chronic low back
pain (CLBP). CLBP is one of the world’s most debilitating
conditions, presenting with substantial socio-economic and
health-care consequences (Vos et al., 2012). Based on our
theoretical concept, the causal therapy for patients with DDD
associated with P. acnes infection is appropriate antibiotic
treatment. However, even if P. acnes infection is successfully
eradicated by antibiotic treatment, ongoing inflammatory
processes with IL-1β playing the central role, along with other
etiological factors, can cause treatment failure.
Since anti-IL-1β drugs have already been approved for
the treatment of inflammatory and autoinflammatory diseases
(Dinarello et al., 2012), therapeutic approaches targeting IL-
1β in combination with appropriate antibiotic treatment,
concomitantly or in sequence, should be considered as a novel
treatment approach. Inhibition of IL-1β signaling can be via
direct targeting of the molecule with biologics or via pro-drug
inhibitors of the inflammasome that target caspase-1 or NLRP3
(Risbud and Shapiro, 2014). As an exemplar of this approach,
treatment of patients with acne using the humanized anti-
IL-1β antibody Gevokizumab demonstrated significant clinical
response with reductions in inflammatory lesions (Fenini et al.,
2017). While acknowledging the complicated nature of DDD,
and the potential for different drivers of inflammation, there
is already promising experimental evidence of the ability of
IL-1β-targeted approaches to affect pathogenic mechanisms
of the condition both in vitro and in vivo, promoting
ECM repair and inhibiting disc degeneration (Gorth et al.,
2012).
The prerequisite for successful CLBP treatment is an accurate
diagnosis. From this perspective, diagnosis of P. acnes infection
and direct evidence of IL-1β over-expression present a strategy to
rationalize a more tailored treatment and management strategy
for patients with DDD, which is essential in a growing era of
precision/ stratified medicine.
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